These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8013094)

  • 1. High-resolution 1H-NMR spectroscopy of blood plasma for metabolic studies.
    Wevers RA; Engelke U; Heerschap A
    Clin Chem; 1994 Jul; 40(7 Pt 1):1245-50. PubMed ID: 8013094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymptomatic 5-oxoprolinuria detected by proton magnetic resonance spectroscopy.
    Ghauri FY; Parkes HG; Nicholson JK; Wilson ID; Brenton DP
    Clin Chem; 1993 Jun; 39(6):1341. PubMed ID: 8504546
    [No Abstract]   [Full Text] [Related]  

  • 3. 5-Oxoprolinuria in patients with and without defects in the gamma-glutamyl cycle.
    Mayatepek E
    Eur J Pediatr; 1999 Mar; 158(3):221-5. PubMed ID: 10094443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unravelling 5-oxoprolinuria (pyroglutamic aciduria) due to bi-allelic OPLAH mutations: 20 new mutations in 14 families.
    Sass JO; Gemperle-Britschgi C; Tarailo-Graovac M; Patel N; Walter M; Jordanova A; Alfadhel M; Barić I; Çoker M; Damli-Huber A; Faqeih EA; García Segarra N; Geraghty MT; Jåtun BM; Kalkan Uçar S; Kriewitz M; Rauchenzauner M; Bilić K; Tournev I; Till C; Sayson B; Beumer D; Ye CX; Zhang LH; Vallance H; Alkuraya FS; van Karnebeek CD
    Mol Genet Metab; 2016 Sep; 119(1-2):44-9. PubMed ID: 27477828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyroglutamic aciduria (5-oxoprolinuria) without glutathione synthetase deficiency and with decreased pyroglutamate hydrolase activity.
    Roesel RA; Hommes FA; Samper L
    J Inherit Metab Dis; 1981; 4(2):89-90. PubMed ID: 6790862
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of the absolute configuration of 2-hydroxyglutaric acid and 5-oxoproline in urine samples by high-resolution NMR spectroscopy in the presence of chiral lanthanide complexes.
    Bal D; Gradowska W; Gryff-Keller A
    J Pharm Biomed Anal; 2002 Jun; 28(6):1061-71. PubMed ID: 12049971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent 5-oxoprolinuria with normal glutathione synthase and 5-oxoprolinase activities.
    Ruijter GJ; Mourad-Baars PE; Ristoff E; Onkenhout W; Poorthuis BJ
    J Inherit Metab Dis; 2006 Aug; 29(4):587. PubMed ID: 16830260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardized method for high-resolution 1H-NMR of cerebrospinal fluid.
    Wevers RA; Engelke U; Wendel U; de Jong JG; Gabreëls FJ; Heerschap A
    Clin Chem; 1995 May; 41(5):744-51. PubMed ID: 7729054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare cause of high anion gap metabolic acidosis.
    Milosevic S; Tran K; O'Brien B
    Intern Med J; 2013 Jan; 43(1):100-1. PubMed ID: 23324093
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-Oxoprolinuria associated with 5-oxoprolinase deficiency; further evidence that this is a benign disorder.
    Henderson MJ; Larsson A; Carlsson B; Dear PR
    J Inherit Metab Dis; 1993; 16(6):1051-2. PubMed ID: 8127060
    [No Abstract]   [Full Text] [Related]  

  • 11. A newborn infant with generalized glutathione synthetase deficiency.
    Yapicioğlu H; Satar M; Tutak E; Narli N; Topaloğlu AK
    Turk J Pediatr; 2004; 46(1):72-5. PubMed ID: 15074378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-oxoprolinuria due to hereditary 5-oxoprolinase deficiency in two brothers--a new inborn error of the gamma-glutamyl cycle.
    Larsson A; Mattsson B; Wauters EA; van Gool JD; Duran M; Wadman SK
    Acta Paediatr Scand; 1981; 70(3):301-8. PubMed ID: 6113726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Oxoprolinuria in an adolescent with chronic metabolic acidosis, mental retardation, and psychosis.
    Robertson PL; Buchanan DN; Muenzer J
    J Pediatr; 1991 Jan; 118(1):92-5. PubMed ID: 1986110
    [No Abstract]   [Full Text] [Related]  

  • 14. Five Chinese patients with 5-oxoprolinuria due to glutathione synthetase and 5-oxoprolinase deficiencies.
    Li X; Ding Y; Liu Y; Ma Y; Song J; Wang Q; Yang Y
    Brain Dev; 2015 Nov; 37(10):952-9. PubMed ID: 25851806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1H-NMR spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism.
    Wevers RA; Engelke UF; Moolenaar SH; Bräutigam C; de Jong JG; Duran R; de Abreu RA; van Gennip AH
    Clin Chem; 1999 Apr; 45(4):539-48. PubMed ID: 10102915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure?
    Liss DB; Paden MS; Schwarz ES; Mullins ME
    Clin Toxicol (Phila); 2013 Nov; 51(9):817-27. PubMed ID: 24111553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glutathion-synthetase deficiency with 5-oxoprolinuria. Two new cases and a review of the literature (author's transl)].
    Boivin P; Galand C; Schaison G
    Nouv Presse Med; 1978 May; 7(18):1531-5. PubMed ID: 673703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic susceptibility to measure total protein concentration from NMR metabolite spectra: Demonstration on blood plasma.
    Jupin M; Michiels PJ; Girard FC; Wijmenga SS
    Magn Reson Med; 2015 Feb; 73(2):459-68. PubMed ID: 24639074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Massive 5-oxoprolinuria with normal 5-oxoprolinase and glutathione synthetase activities.
    Riudor E; Arranz JA; Alvarez R; Carlsson K; del Toro M; Salmerón F; Piñol F; Ristoff E; Sentis M; Larsson A
    J Inherit Metab Dis; 2001 Jun; 24(3):404-6. PubMed ID: 11486906
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.